| Literature DB >> 30134165 |
Yan Wang1, Cheng Zeng2, Jinchen Li3, Zikai Zhou4, Xingda Ju5, Shuting Xia4, Yuanyuan Li2, An Liu4, Huajing Teng1, Kun Zhang6, Leisheng Shi6, Cheng Bi1, Wei Xie4, Xin He7, Zhengping Jia8, Yonghui Jiang9, Tao Cai10, Jinyu Wu6, Kun Xia11, Zhong Sheng Sun12.
Abstract
Synaptic cytoskeleton dysfunction represents a common pathogenesis in neurodevelopmental disorders, such as autism spectrum disorder (ASD). The serine/threonine kinase PAK2 is a critical regulator of cytoskeleton dynamics. However, its function within the central nervous system and its role in ASD pathogenesis remain undefined. Here, we found that Pak2 haploinsufficiency resulted in markedly decreased synapse densities, defective long-term potentiation, and autism-related behaviors in mice. Phosphorylation levels of key actin regulators LIMK1 and cofilin, together with their mediated actin polymerization, were reduced in Pak2+/-mice. We identified one de novo PAK2 nonsense mutation that impaired PAK2 function in vitro and in vivo and four de novo copy-number deletions containing PAK2 in large cohorts of patients with ASD. PAK2 deficiency extensively perturbed functional networks associated with ASD by regulating actin cytoskeleton dynamics. Our genetic and functional results demonstrate a critical role of PAK2 in brain development and autism pathogenesis.Entities:
Keywords: LIMK1; PAK2; actin cytoskeleton; autism; cofilin
Mesh:
Substances:
Year: 2018 PMID: 30134165 DOI: 10.1016/j.celrep.2018.07.061
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423